This page details potential COVID-19 therapeutics. Therapeutic is another word for a treatment. Vaccines are given before someone gets COVID-19 and protects the person from infection, whereas therapeutics are given when someone gets COVID-19.
Substances listed here are not necessarily effective. Medications are detailed because they are on trial for use in COVID-19 or have been described as a potential treatment in an academic paper.
Anti-virals
- Convalescent plasma
- Remdesivir
- GS-441524
- MK-4482 (formerly known as EIDD-2801)
- AT-527
- Favipiravir
- Hydroxychloroquine and Chloroquine
- Dipyridamole
- Niclosamide
- Nitazoxanide
- Doxycycyline
- Ciclesonide
- Interferons
- Camostat mesylate
- Ivermectin
- Indomethacin
- Itraconazole
- Bromhexine
- Galidesivir
- Monoclonal Antibodies
- Amodiaquine
- Soluable ACE2 / ACE2-fc
- Anti-androgens
- Gargles and rinses for COVID-19
- Dual entry inhibition
Host response / anti-inflammatory
- Dexamethasone
- Tocilizumab
- Dipyridamole
- Heparin / enoxaparin
- SSRIs / Fluvoxamine
- Ivermectin
- ARBs
- Baricitinib
- Colchicine
